Biobrace 23Mm
Device Orthopedic Surgery
PDI 00860006566715
General payments
$8,917,405
Research payments
$1,323,893
Through program year 2025, $8,917,405 in general payments and $1,323,893 in research payments were reported against Biobrace 23Mm (Orthopedic Surgery).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,991,152 | 2,093 |
| 2025 | Research | $810,006 | 93 |
| 2024 | General | $2,608,791 | 1,834 |
| 2024 | Research | $472,487 | 57 |
| 2023 | General | $824,362 | 1,416 |
| 2023 | Research | $41,400 | 2 |
| 2022 | General | $3,493,101 | 123 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 43 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 45 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
5,466 general · 152 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.